MGH Huntington's assay passes multicenter study; Blood Dx spots gestational diabetes risk before conception;

> BD Diagnostics won FDA clearance for its new diagnostic test for trichomoniasis. Story

> OPKO Health, a maker of diagnostics and biopharmaceuticals, is now listed in major indices on the Tel Aviv Stock Exchange. Item

> Dako, a cancer diagnostics company, will work with Omnyx (a joint venture of GE Healthcare and the University of Pittsburgh) to provide clinical image analysis for breast cancer digital pathology in Europe. Item

> A blood test designed to test patients at risk of developing Huntington's disease worked successfully in a large multicenter study, Massachusetts General Hospital investigators have concluded. Item

> A blood test could spot women at risk of gestational diabetes before they conceive by identifying whether patients have low levels of the hormone adiponectin, according to a study published recently in the journal Diabetes Care. Story

Suggested Articles

J&J launched a virtual clinical study to gauge whether Apple’s iPhone and ECG-enabled smartwatch can help reduce the risk of stroke and catch AFib.

The Salt Lake City-based developer said its Logix Smart test is now available to be exported from Utah to countries requiring the CE Mark.

Dexcom received a new European approval for its wearable continuous glucose monitor in pregnant women across Type 1, Type 2 and gestational diabetes.